Literature DB >> 9927436

p53 DNA binding can be modulated by factors that alter the conformational equilibrium.

K G McLure1, P W Lee.   

Abstract

The p53 tumor suppressor protein is a dimer of dimers that binds its consensus DNA sequence (containing two half-sites) as a pair of clamps. We show here that after one wild-type dimer of a tetramer binds to a half-site on the DNA, the other (unbound) dimer can be in either the wild-type or the mutant conformation. An equilibrium state between these two conformations exists and can be modulated by two types of regulators. One type modifies p53 biochemically and determines the intrinsic balance of the equilibrium. The other type of regulator binds directly to one or both dimers in a p53 tetramer, trapping each dimer in one or the other conformation. In the wild-type conformation, the second dimer can bind to the second DNA half-site, resulting in drastically enhanced stability of the p53-DNA complex. Importantly, a genotypically mutant p53 can also be in equilibrium with the wild-type conformation, and when trapped in this conformation can bind DNA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927436      PMCID: PMC1171169          DOI: 10.1093/emboj/18.3.763

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  Regulation of the specific DNA binding function of p53.

Authors:  T R Hupp; D W Meek; C A Midgley; D P Lane
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

2.  ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.

Authors:  J MONOD; J WYMAN; J P CHANGEUX
Journal:  J Mol Biol       Date:  1965-05       Impact factor: 5.469

3.  The cellular tumour antigen p53: evidence for transformation-related, immunological variants of p53.

Authors:  J Milner; A Cook
Journal:  Virology       Date:  1986-10-15       Impact factor: 3.616

4.  A new anti-p53 monoclonal antibody, previously reported to be directed against the large T antigen of simian virus 40.

Authors:  J Milner; A Cook; M Sheldon
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

5.  Comparison of experimental binding data and theoretical models in proteins containing subunits.

Authors:  D E Koshland; G Némethy; D Filmer
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

6.  Temperature-dependent switching between "wild-type" and "mutant" forms of p53-Val135.

Authors:  J Milner; E A Medcalf
Journal:  J Mol Biol       Date:  1990-12-05       Impact factor: 5.469

7.  Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein.

Authors:  J Milner; J V Watson
Journal:  Oncogene       Date:  1990-11       Impact factor: 9.867

8.  Evidence for allosteric variants of wild-type p53, a tumour suppressor protein.

Authors:  A Cook; J Milner
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

9.  Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

Authors:  J V Gannon; R Greaves; R Iggo; D P Lane
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

10.  Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation.

Authors:  P Hainaut; J Milner
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more
  7 in total

Review 1.  Hsp70 interactions with the p53 tumour suppressor protein.

Authors:  M Zylicz; F W King; A Wawrzynow
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

2.  p53 associates with and targets Delta Np63 into a protein degradation pathway.

Authors:  E A Ratovitski; M Patturajan; K Hibi; B Trink; K Yamaguchi; D Sidransky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated Activities.

Authors:  George K Annor; Nour Elshabassy; Devon Lundine; Don-Gerard Conde; Gu Xiao; Viola Ellison; Jill Bargonetti
Journal:  Front Cell Dev Biol       Date:  2021-11-22

4.  Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms.

Authors:  Sridharan Rajagopalan; Robert S Sade; Fiona M Townsley; Alan R Fersht
Journal:  Nucleic Acids Res       Date:  2009-11-20       Impact factor: 16.971

5.  Probing potential binding modes of the p53 tetramer to DNA based on the symmetries encoded in p53 response elements.

Authors:  Buyong Ma; Arnold J Levine
Journal:  Nucleic Acids Res       Date:  2007-11-05       Impact factor: 16.971

6.  Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.

Authors:  Giovanna Cenini; Rukhsana Sultana; Maurizio Memo; D Allan Butterfield
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

7.  Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Authors:  P Dong; M Karaayvaz; N Jia; M Kaneuchi; J Hamada; H Watari; S Sudo; J Ju; N Sakuragi
Journal:  Oncogene       Date:  2012-07-30       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.